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Abstract 
Background: Acute respiratory distress syndrome (ARDS) is a life‑threatening condition that often requires pro‑
longed mechanical ventilation. Tracheostomy is a common procedure with some risks, on the other hand with 
potential advantages over orotracheal intubation in critically ill patients. This study investigated the association of 
tracheostomy with health‑related quality of life (HRQoL), symptoms of psychiatric disorders and return‑to‑work of 
ARDS survivors.
Methods: Data were collected in the context of the prospective observational German‑wide DACAPO study. Clinical 
and demographic patient data and treatment characteristics were obtained from the participating intensive care units 
(ICU). HRQoL and return‑to‑work were assessed using patient‑reported questionnaires 3, 6 and 12 months after ICU 
discharge. HRQoL was measured with the Physical and Mental Component Scale of the Short‑Form 12 Questionnaire 
(PCS‑12, MCS‑12). The prevalence of psychiatric symptoms (depression and post‑traumatic stress disorder [PTSD]) was 
assessed using the Patient Health Questionnaire‑9 and the Post‑Traumatic Stress Syndrome‑14. Physician‑diagnosed 
anxiety and obsessive–compulsive disorder were recorded by patient self‑report in the follow‑up questionnaires. The 
associations of tracheostomy with HRQoL, psychiatric symptoms and return‑to‑work after 12 months were investi‑
gated by means of multivariable linear and logistic regression models.
Results: Primary 877 ARDS patients (mean ± standard deviation: 54 ± 16 years, 68% male) survived and were dis‑
charged from ICU. Out of these patients, 478 (54.5%) were tracheotomised during ICU treatment. After 12 months, 
patient‑reported outcomes could be analysed of 388 (44.2%) respondents, 205 with tracheostomy and 183 without. 
One year after ICU discharge, tracheostomy showed no significant association with physical or mental health‑related 
quality of life (PCS‑12: − 0.73 [− 3.96, 2.51]; MCS‑12: − 0.71 [− 4.92, 3.49]), symptoms of psychiatric disorders (depres‑
sion: 0.10 [− 1.43, 1.64]; PTSD: 3.31 [− 1.81, 8.43]; anxiety: 1.26 [0.41, 3.86]; obsessive–compulsive disorder: 0.59 [0.05, 
6.68]) or return‑to‑work (0.71 [0.31, 1.64]) in the multivariable analysis (OR [95%‑CI]).
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Introduction
Acute respiratory distress syndrome (ARDS), a life-
threatening condition characterised by direct or indi-
rect damage to the lung parenchyma causing critical 
hypoxemia with or without hypercapnia [1]. Healthcare 
research in critical care medicine is a relatively new 
field of interest focusing on the influence of organisa-
tional structures, the processes of care on mortality and 
health-related quality of life (HRQoL) of intensive care 
unit (ICU) survivors [2–4]. ARDS survivors experience 
substantial long-term limitations on their physical and 
mental health and have a high risk of developing psy-
chiatric disorders [5–7].
As part of the complex treatment of ARDS, patients 
often need prolonged mechanical ventilation. Pro-
longed endotracheal intubation results in acute 
laryngeal injuries in more than half of patients and is 
associated with significantly worse breathing and voic-
ing up to 10 weeks after extubation [8]. Tracheostomy 
(TT), as the most commonly performed procedure in 
mechanically ventilated ICU patients, may not only 
increase patient comfort by reducing airway resistance 
and dead space but also avoids potential intubation 
injuries such as oropharyngeal and laryngeal lesions. 
The advantages of TT over conventional intubation 
are a shorter duration of sedation and thus promotion 
of early mobilisation and reduced work of breathing, 
which might facilitate weaning from mechanical venti-
lation and hence oral food intake [9]. Nevertheless, the 
TT is an invasive treatment with potential life-threat-
ening risks. Various complications (e.g. haemorrhage, 
infection, pneumothorax, tube obstruction, accidental 
decannulation) have been reported in up to 15% of ICU 
patients [10, 11]. A systematic review described that 
the most common causes of TT-related deaths were 
haemorrhage, loss of airway and false passage [12]. In 
the United States, TT results in death or permanent 
disability in nearly 500 patients each year [11].
To date, outcomes’ research in TT has focused on 
clinical outcomes such as ventilator-free days, dura-
tion of sedation, length of stay in the ICU, mortality 
or survival [13–15]. Patient-reported outcomes such 
as HRQoL or patient-reported symptoms of psychiat-
ric disease have not been investigated so far, nor has 
return-to-work. Also, a long-term follow-up perspec-
tive is missing.
Therefore, the aim of this study was to analyse the asso-
ciation of TT with HRQoL, the prevalence of psychiat-
ric symptoms and return-to-work of ARDS survivors up 
to 1 year after ICU discharge. Our hypotheses were that 
there are possible negative associations between TT and 
HRQoL, the prevalence of psychiatric symptoms and 
return-to-work of ARDS survivors.
Methods
Study design
The frequency of TT in patients with ARDS was observed 
in the context of a large prospective German-wide 
cohort study (DACAPO, acronym of study title: Surviv-
ing ARDS: the influence of quality of care and individual 
patient characteristics on quality of life, ClinicalTrials.
gov Identifier: NCT02637011). The study was approved 
by the Ethics Committee of the University of Regens-
burg (original approval: December 2013, approval of an 
amendment: June 2014; file number 13-101-0262) and (if 
necessary) by the Ethics Committees of the participating 
study centres. The baseline characteristics and profile of 
the cohort have been described in more detail elsewhere 
[16, 17]. ARDS survivors were asked to complete com-
prehensive self-report questionnaires 3, 6 and 12 months 
after their discharge from the ICU.
Patient cohort
Figure 1 gives an overview of the sample size at the dif-
ferent time points of the study. The study preliminarily 
included patients with ARDS (according to the Berlin 
definition [18]) who had been treated at one of 61 ICUs 
across Germany between September 2014 and April 
2016. Written informed consent was obtained from 1.225 
patients. Written informed consent was given by the 
patients or their caregivers or legal guardians during the 
ICU length of stay.
Out of 877 ICU survivors, 388 (44.2%) had returned the 
questionnaire at 12  months. The most frequent reason 
for dropping out of the study was death after discharge 
from the ICU (N = 158). Other reasons included inabil-
ity to complete the questionnaire (insufficient knowledge 
of German or incapability due to morbidity), absence of 
a person who could provide proxy reports, withdrawal of 
consent or an invalid address.
The primary endpoint of this study was HRQoL (Short 
Form-12 self-report questionnaire [SF-12]) of ARDS 
Conclusions: Up to 1 year after ICU discharge, neither HRQoL nor symptoms of psychiatric disorders nor return‑to‑
work was affected by tracheostomy.
Trial registration NCT02637011 (ClinicalTrials.gov, Registered 15 December 2015, retrospectively registered)
Keywords: Tracheostomy, ARDS, Intensive care, Health‑related quality of life, Return‑to‑work
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survivors up to 1  year after ICU discharge. Secondary 
endpoints were the prevalence of psychiatric symptoms 
and return-to-work up to 1 year after ICU discharge.
Data collection and measurement instruments
Characteristics of patients (age, sex), disease (Sequen-
tial Organ Failure Assessment [SOFA] Score, Simplified 
Acute Physiology Score [SAPS II] and ARDS severity) and 
treatment (TT, prone position and extracorporeal mem-
brane oxygenation) as well as information on mortality 
or discharge from the ICU were reported by study physi-
cians or study assistants of the participating ICUs using 
the electronic data capture system OpenClinica (Open-
Clinica, LLC; https ://www.openc linic a.com/). Informa-
tion on HRQoL and return-to-work was assessed by 
means of self-report questionnaires at 3, 6 and 12 months 
after discharge from the ICU. ARDS survivors completed 
the Short Form-12 self-report questionnaire (SF-12) as a 
measure of HRQoL and questionnaires on psychopathol-
ogy. The prevalence of psychiatric symptoms (depression 
and post-traumatic stress disorder [PTSD]) was assessed 
using the Patient Health Questionnaire-9 [PHQ-9] and 
the Post-Traumatic Stress Syndrome-14 [PTSS-14]. 
Furthermore, patients were asked whether depression, 
PTSD, anxiety or obsessive compulsive disorder (OCD) 
had been diagnosed by a physician after ICU discharge. 
For the screening tools, the cut-off values for being at 
risk of depression were defined as PHQ-9 (≥ 5) and for 
PTSD as PTSS-14 [≥ 45]) [19, 20]. The published scor-
ing algorithm of the SF-12 resulted in the Physical Com-
ponent Summary (PCS-12) and the Mental Component 
Summary (MCS-12) scores [21]. Scores range from 0 to 
100 (higher values indicate better HRQoL), and a score of 
50 represents the mean value for the general population 
(German norm values) [22, 23]. The measuring instru-
ments of HRQoL are described in detail elsewhere [16].
Statistical analyses
The analyses presented here were pre-specified at the 
design stage of the study. Data are shown as mean ± SD 
for continuous and as absolute and relative frequencies 
for categorical variables. The Student’s t test and the Chi 
squared test of independence were used for comparing 
tracheotomised and non-tracheotomised patients. We 
Fig. 1 Consort statement—flow chart of ARDS patients throughout the study (areasons for drop‑out for all patients: unable to participate in the 
study or to understand German, declined participation; incorrect address or new address unknown, organisational failure; survival was assessed by 
means of local municipal population registries)
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tested whether there was systematic variance between 
ICUs in relation to the primary outcome at the three 
follow-ups. These analyses yielded an intraclass corre-
lation coefficient (ICC) close to zero based on the fully 
unconditional model and non-significant p values for 
the likelihood ratio tests. For this reason, fixed-effects 
linear and logistic regression models were applied. The 
predictive value of TT on HRQOL, psychiatric symp-
toms and return-to-work after 12 months were assessed 
by means of multiple linear and multivariable logistic 
regression models. The following patient- and treatment-
related confounders were used: patient age, sex, SOFA 
Score, SAPS II, ARDS severity, body mass index (BMI) 
and length of ICU stay. The regression coefficient B for 
the linear regression models and the OR for the logis-
tic regression model were calculated as effect estimates, 
both accompanied by the corresponding 95%-confidence 
intervals (95%-CI). A p value of < 0.05 was considered sig-
nificant. Due to the exploratory nature of this study, no 
adjustments for multiple comparisons were made. All 
analyses were performed using the software R (Version 
3.5.1, http://www.r-proje ct.org).
Results
Out of 1900 patients meeting ARDS criteria, 1205 
patients could be analysed (Fig. 1). Of whom 659 (54.7%) 
had been tracheotomised during ICU treatment. 68% of 
this patient cohort were men; the mean age was 56 years 
(± 15.8). The characteristics of patients with and without 
TT are shown in Table  1. The body mass index (BMI) 
was significantly higher in the group of tracheotomised 
patients (p = 0.010). The two groups did not differ with 
regard to illness severity, which was measured by the 
SAPS II at ICU admission, the SOFA score and ARDS 
severity at the time of ARDS diagnosis. For all 1205 
patients, the median duration of mechanical ventilation 
was 16 days (IQR 10–27) and that of ICU length of stay 
22 days (IQR 14–36). The median duration of ventilation 
(20 days [IQR 13–29] vs. 11 days [IQR 6–16], p < 0.001) 
and ICU stay (p < 0.001, Table 1) was twice as long for tra-
cheotomised patients. Primary 877 ARDS patients sur-
vived and discharged from ICU. Out of these patients 478 
(54.5%) were tracheotomised.
The employment status of ARDS patients before and 
after ICU treatment is shown in Table  2. 328 (43.3%) 
ARDS survivors had worked full-time or part-time before 
their critical illness. After 1 year, 186 (54.2%) of the 
respondents had returned to work within a median time 
of 114 days (IQR 72–190) after ICU discharge. Univari-
ate analysis showed that tracheotomised patients were 
less likely to have returned to work after 12 months than 
non-tracheotomised patients (35% vs. 64%, p < 0.001). 
This association could not be shown in the multivariable 
analysis (p = 0.416) (see Table 4).
According to SF-12 measurement, ARDS survivors 
had lower HRQoL compared to the score validated 
from the general population. The differences in PCS-12 
and MCS-12 between ARDS survivors with and with-
out TT across the follow-up time points are shown in 
Fig. 2. In the univariate analysis, patients with TT had 
significantly worse PCS-12 scores than non-tracheot-
omised patients across all measured time points after 
Table 1 Patient characteristics of the ICU sample (n = 1205)
ARDS acute respiratory distress syndrome, BMI body mass index, ICU intensive care unit, SAPS Simplified Acute Physiology Score, SOFA sequential organ failure 
assessment
*p < 0.05
a Measured at the time of ARDS diagnosis
b Measured at ICU admission
Tracheostomy (n = 659) Non-tracheostomy 
(n = 546)
p value Missing (n)
Age (years), mean (± SD) 56.41 (± 14.87) 56.01 (± 16.89) 0.663 0
Sex
 Men, n (%) 454 (69%) 368 (67%) 0.580 0
 Women, n (%) 205 (31%) 178 (33%)
BMI (kg/m2), mean (± SD) 29.62 (± 9.34) 28.29 (± 6.94) 0.010* 154
Severity of  ARDSa
 Mild, n (%) 46 (9%) 44 (10%) 0.711 273
 Moderate, n (%) 224 (44%) 182 (42%)
 Severe, n (%) 238 (47%) 211 (48%)
SAPSb, mean (± SD) 65 (± 41.36) 51 (± 41.02) 0.655 124
SOFA  scorea, mean (± SD) 8.46 (± 3.58) 8.10 (± 3.34) 0.098 148
Duration of ICU stay, days, median (IQR) 30 (20–44) 15 (10–23) < 0.001* 44
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ICU discharge (Fig. 2; Table 3), but no significance was 
found in the multivariable analysis (Table  4). In the 
univariate analysis, MCS-12 scores were significantly 
impaired for tracheotomised patients 3  months after 
ICU discharge (p = 0.016) but did not differ between 
the two groups after 6 and 12 months (Fig. 2). The mul-
tivariable analysis of MCS-12 did not show any differ-
ences 1  year after ICU discharge (p = 0.834) (Table  4). 
In the univariate and multivariate analyses, psychiatric 
symptoms (PHQ-9, PTSS-14) and reported psychiatric 
disorders (depression, PTSD, anxiety and OCD) had 
not been affected by TT in patients up to 1  year after 
ARDS (Tables 3 and 4).
Discussion
This study analysed the influence of TT on HRQoL, 
prevalence of psychiatric symptoms and return-to-work 
in 388 ARDS survivors 1  year after ICU discharge. The 
main finding was that TT was not significantly associated 
with physical (PCS-12) or mental impairment in quality 
of life (MCS-12). Secondary findings were (1) TT was not 
significantly related to the prevalence of psychiatric dis-
orders and (2) TT was not significantly associated with 
return-to-work of ARDS survivors after 12 months.
Thus, the hypotheses underlying this study could not 
be confirmed. However, we did observe that TT was 
associated with a significant increase of ICU length of 
stay. ICU length of stay is a known independent factor 
Table 2 Univariate analysis of the employment status of ARDS patients before ICU treatment and return-to-work
Return-to-work could only analysed in patients which worked before the critical illness
ICU intensive care unit
*p < 0.05
Tracheostomy Non-tracheostomy p value Missing (n)
ICU sample (n = 1205)
 Previous employment, n (%) 211 (36.1) 197 (40.6) 0.133 136
 No previous employment, n (%) 373 (63.9) 288 (59.4)
ICU survivors (n = 877)
 Previous employment, n (%) 162 (39) 166 (48.4) 0.01* 119
 No previous employment, n (%) 253 (61) 177 (51.6)
Respondents after 12 months (n = 388)
 Return‑to‑work, n (%) 34 (35) 66 (64) p < 0.001* 189
Fig. 2 Univariate analysis of Short Form‑12 (SF‑12) self‑report response of ARDS survivors across follow‑up time points (*p < 0.05; means and 
95%‑CI). a Physical Component Summary of SF‑12 [PCS‑12]. b Mental Component Summary of SF‑12 [MCS‑12]); the mean score of the general 
population is 50; one standard deviation is marked in grey
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associated with increased stationary healthcare use 
and 1-year mortality after ICU discharge and should be 
considered when deciding for the best time point of TT 
in critical ill patients [24, 25]. In our study, associations 
observed in univariate analyses were lost mainly due to 
the strong confounding effect of ICU length of stay.
A current systematic review of patient-important out-
comes for critically ill patients in randomised controlled 
clinical studies has shown ICU mortality to be the most 
frequently measured clinical outcome. Only 10% of stud-
ies have included at least one patient-important out-
come in addition to mortality after ICU discharge [26]. 
Table 3 Univariate analysis of HRQoL and symptoms of psychiatric disorders in ARDS survivors after 12 months (n = 388)
MCS-12 Mental Component Scale of Short-Form 12 Questionnaire, PCS-12 Physical Component Scale of Short-Form 12 Questionnaire, OCD obsessive–compulsive 
disorder, PTSD post-traumatic stress disorder, PHQ-9 Patient Health Questionnaire-9, PTSS-14 Post-Traumatic Stress Syndrome 14-Questions Inventory
*p < 0.05
a Health-related quality of life and symptoms of psychiatric disorders (depression, PTSD) were diagnosed according to the results of patient self-reported 
questionnaires
b Psychiatric disorders diagnosed by a physician were recorded by patient self-report in the follow-up questionnaires
Tracheostomy (n = 205) Non-tracheostomy 
(n = 183)
p value Missing (n)
PCS‑12a, mean (± SD) 40.3 (± 10.8) 43.9 (± 11.0) 0.005* 83
MCS‑12a, mean (± SD) 44.5 (± 12.8) 44.3 (± 14.0) 0.887 83
PHQ‑9a, mean (± SD) 6.5 (± 5.1) 6.1 (± 5.4) 0.517 24
PTSS‑14a, mean (± SD) 35.3 (± 18.0) 32.6 (± 17.6) 0.156 25
Depressionb
 Yes, n (%) 32 (16%) 18 (10%) 0.078 18
Anxiety  disorderb
 Yes, n (%) 20 (10%) 11(6%) 0.170 34
PTSDb
 Yes, n (%) 20 (10%) 16 (9%) 0.721 22
OCDb
 Yes, n (%) 6 (3%) 5 (3%) 0.883 27
Table 4 Multivariable linear and  logistic regression models on  HRQoL, psychiatric symptoms and  return-to-work 
after 12 months (adjusted for age, sex, BMI, severity of ARDS, SOFA score, SAPS-II and length of ICU stay)
B regression coefficient, 95%-CI 95% confidence interval, MCS-12 Mental Component Scale of Short-Form 12 Questionnaire, OCD obsessive–compulsive disorder, OR 
odds ratio, PCS-12 Physical Component Scale of Short-Form 12 Questionnaire, PTSD post-traumatic stress disorder, PHQ-9 Patient Health Questionnaire-9, PTSS-14 
Post-Traumatic Stress Syndrome 14-Questions Inventory
*p < 0.05
a Health-related quality of life and symptoms of psychiatric disorders (depression, PTSD) were diagnosed according to the results of patient self-reported 
questionnaires
b Psychiatric disorders diagnosed by a physician were recorded by patient self-report in the follow-up questionnaires
Dependent variable Independent variable B (95%-CI) p
PCS‑12a (n = 305) Tracheostomy − 0.73 (− 3.96, 2.51) 0.659
MCS‑12a (n = 305) Tracheostomy − 0.71 (− 4.92, 3.49) 0.739
PHQ‑9a (n = 364) Tracheostomy 0.10 (− 1.43, 1.64) 0.894
PTSS‑14a (n = 363) Tracheostomy 3.31 (− 1.81, 8.43) 0.204
OR (95%-CI)
Depressionb (n = 370) Tracheostomy 1.52 (0.61, 3.78) 0.368
Anxiety  disorderb (n = 354) Tracheostomy 1.26 (0.41, 3.86) 0.691
PTSDb (n = 366) Tracheostomy 0.91 (0.29, 2.82) 0.870
OCDb (n = 361) Tracheostomy 0.59 (0.05, 6.68) 0.667
Return‑to‑workb (n = 199) Tracheostomy 0.71 (0.31, 1.64) 0.416
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It should be noted that, in contrast to mortality, HRQoL 
is a complex construct that contains individual aspects 
with multiple dimensions, often operationalised as social, 
somatic and psychological variables [4]. The individual 
dimensions of HRQoL could be recorded by different 
measurement tools and must be correlated for a bet-
ter comparison of patient-reported outcomes [27]. In an 
Italian study, 137 tracheotomised patients with respira-
tory and neurological diseases were analysed in relation 
to ICU mortality and HRQoL. Patients tracheotomised 
because of respiratory disease had a high ICU mortality 
rate of 50%; only 25 patients (20.5%) were still alive after 
1 year. HRQoL of all tracheotomised patients was moder-
ately compromised after 1 year, but the group of patients 
with respiratory diseases showed better HRQoL dur-
ing follow-up [28]. In the present study, HRQoL was not 
impaired by TT.
Symptoms of psychiatric disorders were often reported 
after survival of ARDS [6, 29]. As an example, up to 27% 
of critical illness survivors suffered from PTSD, and 
depression was reported in 40% of ARDS survivors [30, 
31]. In the present study, TT did not influence the occur-
rence of psychiatric disorders. According to the results 
of the self-reported questionnaires shown in Tables  3 
and 4, 25.9% of ARDS survivors had symptoms of PTSD 
(cut-off scores for symptoms of PTSD: ≥ 45) and 55.6% 
symptoms of depression (PHQ-9 score ≥ 5) at the 1-year 
follow-up [19, 20].
Furthermore, TT did not affect return-to-work in 
ARDS survivors in this study. More than 50% of 1-year 
survivors had returned to work after a median of 
16 weeks after ICU discharge. Considering the different 
socioeconomic systems, an US survey including 379 pre-
viously employed ARDS survivors found that 213 (56%) 
patients had returned to work after a median of 13 weeks 
after hospital discharge [32]. Nevertheless, the fact 
remains that nearly 50% of patients were unemployed, 
which may have resulted in family problems and loss of 
substantial earnings. A 5-year follow-up of ARDS survi-
vors showed that nearly one-third of previously employed 
ARDS survivors had never returned to work [33].
TT is one of the most common surgical procedures in 
patients with acute respiratory failure. TT practices vary 
substantially amongst disciplines, ICUs and institutions 
[34]. The TT rate of 55% found in this Germany-wide 
study seems to be rather high and could be explained by 
the inclusion of a higher number of patients with severe 
ARDS. In the worldwide LUNG-SAFE study, only 13% 
of patients with ARDS had received TT during their 
length of ICU stay; yet, the rate in European countries 
was higher at 15.7% [15]. The ICU length of stay was also 
significantly longer for patients with TT (11 vs. 8 days). 
One possible explanation might be that the transfer of 
tracheostomised patients to a normal ward is difficult 
because of the elaborate airway management and more 
intensive care. Freeman and colleagues analysed over 
44,000 patients with acute respiratory failure (10.8% of 
patients with TT) and found longer ICU treatment (24 
vs. 7 days) in tracheotomised patients [35]. In our study, 
the BMI was significantly higher in the tracheotomised 
group. A recent study from the US which also investi-
gated patient factors associated with 30-day survival after 
TT did not find any influence of BMI and socioeconomic 
factors [13].
Strengths and limitations
The strengths of the present study are its prospective 
design with three time point of follow-ups, the large 
number of included patients with ARDS from hospitals 
across Germany and the detailed collection of data on 
HRQoL and individual patient characteristics. Despite 
our best efforts to follow up each patient, the number of 
drop-outs was rather high, which may have resulted in 
attrition bias limiting this study. The instruments used 
for screening mental disorders do not allow making diag-
noses such as major depression disorders and PTSD; only 
symptoms or the risk of being affected by such a disorder 
could be recorded. To the best of our knowledge, this is 
the largest multicentre study investigating the association 
of TT with return-to-work and patient-reported HRQoL 
as well as symptoms of psychiatric disorders and return-
to-work in ARDS survivors.
Conclusion
In summary, TT resulted in prolonged intensive care 
treatment of ARDS survivors but did not seem to have an 
association with physical or mental HRQoL, symptoms 
of psychiatric disorders or return-to-work 1  year after 
ICU discharge.
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